Skip to content
Disclosery

Euclidean Capital LLC

Follow

13F filer, CIK 1825034, NEW YORK, NY

Euclidean Capital LLC reported $439,836,054 across 11 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 100% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001012975-26-000776

Period
2026-06-30
Reported value
$440M
Holdings
11
Top 10 weight
100%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TMSnew+1,099,974$9.04M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001012975-26-000776, largest first. % of portfolio is the value over $439,836,054, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
VEUVANGUARD INTL EQUITY INDEX FQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 507,600 shares; 2024Q4: 1,013,434 shares; 2025Q1: 1,991,884 shares; 2025Q2: 2,142,684 shares; 2025Q3: 2,578,184 shares; 2025Q4: 2,990,084 shares; 2026Q1: 3,243,484 shares; 2026Q2: 3,243,484 shares 3,243,484$272M61.76%0Timeline
VTVVANGUARD INDEX FDSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 520,000 shares; 2026Q1: 520,000 shares; 2026Q2: 520,000 shares 520,000$113M25.76%0Timeline
INDAISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,425,144 shares; 2024Q4: 2,425,144 shares; 2025Q1: 2,425,144 shares; 2025Q2: 2,425,144 shares; 2025Q3: 369,600 shares; 2025Q4: 369,600 shares; 2026Q1: 369,600 shares; 2026Q2: 369,600 shares 369,600$18.3M4.15%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 989,410 shares; 2024Q4: 989,410 shares; 2025Q1: 989,410 shares; 2025Q2: 989,410 shares; 2025Q3: 989,410 shares; 2025Q4: 989,410 shares; 2026Q1: 989,410 shares; 2026Q2: 989,410 shares 989,410$10.7M2.44%0Timeline
TMSTEAMSHARES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,099,974 shares 1,099,974$9.04M2.06%newTimeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,573,761 shares; 2024Q4: 1,573,761 shares; 2025Q1: 1,573,761 shares; 2025Q2: 1,573,761 shares; 2025Q3: 1,573,761 shares; 2025Q4: 1,573,761 shares; 2026Q1: 1,573,761 shares; 2026Q2: 1,573,761 shares 1,573,761$7.68M1.75%0Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,627,643 shares; 2024Q4: 2,627,643 shares; 2025Q1: 2,627,643 shares; 2025Q2: 2,627,643 shares; 2025Q3: 2,627,643 shares; 2025Q4: 2,627,643 shares; 2026Q1: 2,627,643 shares; 2026Q2: 2,627,643 shares 2,627,643$3.52M0.8%0Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,307,858 shares; 2024Q4: 1,307,858 shares; 2025Q1: 1,307,858 shares; 2025Q2: 1,307,858 shares; 2025Q3: 1,307,858 shares; 2025Q4: 1,307,858 shares; 2026Q1: 1,307,858 shares; 2026Q2: 1,307,858 shares 1,307,858$2.63M0.6%0Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 87,696 shares; 2024Q4: 87,696 shares; 2025Q1: 87,696 shares; 2025Q2: 87,696 shares; 2025Q3: 87,696 shares; 2025Q4: 87,696 shares; 2026Q1: 87,696 shares; 2026Q2: 87,696 shares 87,696$2.28M0.52%0Timeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,015,705 shares; 2024Q4: 1,015,705 shares; 2025Q1: 1,015,705 shares; 2025Q2: 1,015,705 shares; 2025Q3: 1,015,705 shares; 2025Q4: 1,015,705 shares; 2026Q1: 1,015,705 shares; 2026Q2: 1,015,705 shares 1,015,705$751K0.17%0Timeline
SRZNWSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 170,833 shares; 2024Q4: 170,833 shares; 2025Q1: 170,833 shares; 2025Q2: 170,833 shares; 2025Q3: 170,833 shares; 2025Q4: 170,833 shares; 2026Q1: 170,833 shares; 2026Q2: 170,833 shares 170,833$2.82K<0.01%0Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001012975-26-000776 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001012975-26-000776 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001012975-26-000442 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001012975-26-000154 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001012975-25-000761 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001012975-25-000445 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001012975-25-000241 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001012975-25-000088 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001012975-24-000483 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001012975-24-000328 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001012975-24-000215 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001012975-24-000089 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR/A 0001012975-23-000496 Quarter ended 2023-09-302023-12-01acceptance time not in the bulk data set
13F-HR 0001012975-23-000467 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001012975-23-000341 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001012975-23-000226 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001012975-23-000092 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001012975-22-000490 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001012975-22-000358 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001012975-22-000235 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001012975-22-000083 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001012975-21-000458 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR/A 0001012975-21-000457 Quarter ended 2021-06-302021-11-15acceptance time not in the bulk data set
13F-HR 0001012975-21-000313 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001012975-21-000218 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001012975-21-000077 Quarter ended 2020-12-312021-02-12acceptance time not in the bulk data set